Total Funding
36
53
Total FundingSeed raised
Growth Score 36 in past quarter
-2 pts
Heat Score 53 in past quarter
-18 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
216937
Genechron is a Biotechnology Company.
- Vittorio Rosato: President
- Roberta Gioia: CEOPast Role: Università degli Studi di Palermo (UNIPA), Advisor Progetto AIDA
About the Company
Genechron is a biotech company specialized in molecular diagnostics, in the analysis of molecular markers on tissues and biological samples. Their services can be used for diagnostic purposes, for the transfer of human therapies from the pre-clinical field to the clinical field, for nutrigenetic analysis and for veterinary applications. The
company, founded in 2016, has subsequently received capital risk financing through the POR I.3 Venture Capital Fund of the Lazio Region through Lazio Innova Spa.